Lidogrell is a dual-acting agent that can be used to prevent systemic thromboembolism and as an adjunct to thrombolytic therapy in acute myocardial infarction.

110140-89-1

C18H17F3N2O3

366.33

R70416;R-68070;R-70416;R 70416;R68070;R 68070;Ridogrel

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years